Managing Antiplatelet Therapy in Patients with Acute Coronary Syndrome

Published Online: Monday, March 25, 2013
Follow Pharmacy_Times:
In this podcast, Toby Trujillo, PharmD, BCPS, an associate professor at the University of Colorado Denver School of Pharmacy, discusses issues related to options for managing antiplatelet therapy in patients with acute coronary syndrome. To listen to the podcast, click here.
Related Articles
Studies have reported that up to half of patients discontinue prescribed therapies soon after hospital discharge.
FDA officials have recommended approval for Amgen’s proposed cholesterol-lowering medication, evolocumab (Repatha).
Pharmacists know changes in vitamin K intake can drastically alter INR values in patients taking warfarin.
Acute coronary syndrome is clearly a problem in the elderly population, especially since survival declines with increasing age.
Latest Issues
$auto_registration$